"Anxiolytic" action of diazepam and abecarnil in a modified open field test

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 4, 1996, Pages 1005-1011

  Rex, A ^a   Stephens, D N ^b   Fink, H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Abecarnil; Anxiety; Benzodiazepine; Diazepam; Feeding; Hyperphagia; Plus maze

Indexed keywords

ANIMALIA;

ABECARNIL; ANXIOLYTIC AGENT; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BETA CARBOLINE DERIVATIVE; DIAZEPAM; FLUMAZENIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; FOOD DEPRIVATION; FOOD INTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CARBOLINES; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; EXPLORATORY BEHAVIOR; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR;

EID: 0029968882     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02121-3     Document Type: Article

References (43)

1. Balfour, D. J. K.; Graham, C. A.; Vale, A. L. Studies on the possible role of brain 5-HT systems and adrenocortical activity in behavioural responses to nicotine and diazepam in an elevated X-maze. Psychopharmacology (Berlin) 90:528-532; 1986.
2. Ballinger, B. R. Hypnotics and anxiolytics. Br. Med. J. 300:456-458; 1990.
3. Bodnoff, S. R.; Suranyi-Cadotte, B.; Quirion, R.; Meaney, M. J. A comparison of the effects of diazepam vs. several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berlin) 97:277-279; 1989.
4. Britton, D. R.; Britton, K. T. A sensitive open field measure of anxiolytic drug activity. Pharmacol. Biochem. Behav. 15(4):577-582; 1981.
5. Cadogan, A. K.; Fink, H.; Kendall, D. A.; Marsden, C. A. Aversion increases 5-HT release and cyclic AMP efflux in the rat. Soc. Neurosci. Abstr. 19:1993.
6. Chopin, P.; Briley, M. Animal models of anxiety: The effect of compounds that modify 5-HT neurotransmission. Trends Pharmacol. Sci. 8:383-388; 1987.
7. Cook, L.; Sepinwall, J. Behavioural analysis of the effects and mechanisms of action of benzodiazepines. In: Costa, E.; Greengard, P., eds. Mechanisms of actions of benzodiazepines. New York: Raven Press; 1975:1-28.
8. Cooper, S. J. Benzodiazepines as appetite-enhancing compounds. Appetite 1:7-19; 1980.
9. Cooper, S. J.; Greenwood, S. E. The beta-carboline abecarnil, a novel agonist at central benzodiazepine receptors, influences saccharin and salt taste preferences in the rat. Brain Res. 18(1): 144-147; 1992.
10. Costall, B.; Domeney, A. M.; Gerrard, P. A.; Kelly, M. E.; Naylor, R. J. Zacopride: Anxiolytic profile in rodent and primate models of anxiety. J. Pharm. Pharmacol. 40:302-305; 1988.
11. Duka, T.; Schuett, B.; Krause, W.; Dorow, R.; McDonald, S.; Fichte, K. Human studies on abecarnil a new beta-carboline anxiolytic: Safety, tolerability and preliminary pharmacological profile. Br. J. Clin. Pharmacol. 35(4):386-394; 1993.
12. File, S. E.; Lister, R. G.; Nutt, D. J. The anxiogenic action of benzodiazepine antagonists. Neuropharmacology 21:1033-1037; 1982.
13. File, S. E.; Lister, R. G.; Nutt, D. J. Intrinsic actions of benzodiazepine antagonists. Neurosci. Lett. 32:165-168; 1982.
14. File, S. E.; Pellow, S. The anxiogenic action of Ro 15-1788 is reversed by chronic, but not by acute, treatment with chlordiazepoxide. Brain Res. 310:154-156; 1984.
15. File, S. E.; Pellow, S. The benzodiazepine receptor antagonist Ro 15-1788 has anxiogenic activity in four animal tests of anxiety. Br. J. Pharmacol. 84:103P; 1985.
16. Geller, I.; Seifter, J. The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482-492; 1960.
17. Green, S. Benzodiazepines, putative anxiolytics and animal models of anxiety. Trends. Neurosci. 14:101-104; 1991.
18. Guimaraes, F. S.; Chiaretti, T. M.; Graeff, F. G.; Zuardi, A. W. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology (Berlin) 100:558-559; 1990.
19. Handley, S. L.; Mithani, S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of "fear"-motivated behaviour. Naunyn Schmiedeberg Arch. Pharmacol. 327:1-5; 1984.
20. Holm, M. Prescription of benzodiazepines in general practice in the county of Arhus, Denmark. Dan. Med. Bull. 35(5):495-499; 1988.
21. Johnson, D. N. Effect of diazepam on food consumption in rats. Psychopharmacologia 56:111-112; 1978.
22. Jones, G. H.; Schneider, C.; Schneider, H. H.; Seidler, J.; Cole, B. J.; Stephens, D. N. Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: An analysis based on fractional receptor occupancies. Psychopharmacology (Berlin) 114(2):191-199; 1994.
23. Lader, M. Animal modls odf anxiety: A clinical perspective In: Willner, P., ed. Behavioural models in psychopharmacology: Theoretical, industrial and clinical perspectives. Cambridge: University Press; 1991:76-88.
24. Lister, R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92:180-185; 1987.
25. Lister, R. G. Ethologically based animal models of anxiety disorders. Pharmacol. Ther. 46:321-340; 1990.
26. Löscher, W.; Honack, D.; Scherkl, R.; Hashem, A.; Frey, H. H. Pharmacokinetics, anticonvulsant efficacy and averse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs. J. Pharmacol. Exp. Ther. 255(2):541-548; 1990.
27. Luscombe, G. P.; Mazurkiewicz, S. E.; Buckett, W. R. Flumazenil antagonises the anxiolytic effect of chlordiazepoxide, buspirone and dothiepin in the elevated plus-maze. Br. J. Pharmacol. 104:216P; 1991.
28. Merlo-Pich, E.; Samanin, R. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat. Pharmacol. Res. 21(5):595-602; 1989.
29. Montgomery, K. C. The relation between fear induced by novel stimulation and exploratory behaviour. J. Comp. Physiol. Psychol. 48:254-260; 1955.
30. 1A selective ligand and its effects in animal models of anxiety: Comparison with buspirone, 8-OH-DPAT and diazepam. Br. J. Pharmacol. 99:343-349; 1990.
31. Pellow, S.; Chopin, P.; File, S. E.; Briley, M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167; 1985.
32. Pellow, S.; File, S. E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24:525-529; 1986.
33. Poschel, B. P. H. A simple and specific screen for benzodiazepine-like drugs. Psychopharmacologia 19:193-198; 1971.
34. Rex, A.; Marsden, C. A.; Fink, H. Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus-maze. Psychopharmacology (Berlin) 110:490-496; 1993.
35. Robertson, H. A.; Riives, M. L. A benzodiazepine antagonist is an anticonvulsat in an animal model for limbic epilepsy. Brain Res. 270:380-382; 1983.
36. Rohmer, J. G.; Di Scala, G.; Sandner, G. Behavioral analysis of the effects of benzodiazepine receptor ligands in the conditioned burying paradigm. Behav. Brain Res. 38:45-54; 1990.
37. Stephens, D. N.; Meldrum, B. S.; Weidmann, R.; Schneider, C.; Grützner, M. Does the excitatory amino acid receptor antagonist 2-AHP exhibit anxiolytic activity? Psychopharmacology (Berlin) 90:166-169; 1986.
38. Stephens, D. N.; Andrews, J. S. Screening for anxiolytic drugs. In: Willner, P., ed. Behavioural models in psychopharmacology: Theoretical, industrial and clinical perspectives. Cambridge: University Press; 1991:50-75.
39. Stephens, D. N.; Schneider, H. H.; Kehr, W.; Andrews, J. S.; Rettig, K.-J.; Turski, L.; Schmiechen, R.; Turner, J. D.; Jensen, L. H.; Petersen, E. N.; Honore, T.; Hansen, J. B. Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors. J. Pharmacol. Exp. Ther. 253:334-338; 1990.
40. Taukulis, H. K.; Goggin, C. E. Diazepam-stress interactions in the rat: Effects on autoanalgesia and a plus-maze model of anxiety. Behav. Neural Biol. 53:205-216; 1990.
41. Vogel, J. R.; Beer, B.; Clody, D. E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1-7; 1971.
42. Wright, I. K.; Heaton, M.; Upton N.; Marsden, C. A. Comparison of acute and chronic treatment of diazepam and ritanserin in the elevated plus-maze model of anxiety. In: Briley, M.; File, S. E., eds. New concepts in anxiety. London: Macmillan Press; 1991:277-287.
43. Wright, I. K.; Upton, N.; Marsden, C. A. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berlin) 109:338-346; 1992.